General MedicationsINJECTIONGeneric

CARBOCAINE W/ NEO-COBEFRIN

LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE

Standard Dose

0.05MG/ML;2%

Max Dose

Refer to approved labeling

Primary Use

Review priority: PRIORITY Marketing status: Discontinued

Summary

Approval overview CARBOCAINE W/ NEO-COBEFRIN is listed in Drugs@FDA under application 012125 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.05MG/ML;2% Sponsor EASTMAN KODAK Submission history Latest submission status date: 1992-03-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview CARBOCAINE W/ NEO-COBEFRIN is listed in Drugs@FDA under application 012125 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.05MG/ML;2% Sponsor EASTMAN KODAK Submission history Latest submission status date: 1992-03-04 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: PRIORITY

Interaction Notes

No interaction notes stored yet.